Related Experiment Video

Updated: Sep 7, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Immunotherapy: are we making a difference?

J P Dutcher1

  • 1New York Medical College and Our Lady of Mercy Cancer Centre, Bronx 10466, USA. jpd4401@aol.com

Current Opinion in Urology
|September 27, 2000
PubMed

Insights

Immunotherapy for metastatic renal cell cancer shows anti-tumour effects in some patients. Ongoing research focuses on new immune activation technologies to improve response rates and outcomes.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Immunotherapy has a 10-20 year history in treating metastatic renal cell cancer.
  • Current immunotherapeutic agents demonstrate anti-tumour effects in a subset of patients.
  • Dosing and scheduling of existing treatments are continually refined.

Purpose of the Study:

  • To explore advancements in immunotherapeutic approaches for metastatic renal cell cancer.
  • To investigate new technologies for enhancing immune system activation.
  • To improve response rates and patient outcomes in renal cell cancer treatment.

Main Methods:

  • Review of historical and current immunotherapeutic strategies.
  • Analysis of emerging immune system activation technologies.
  • Evaluation of anti-proliferative effects and stable disease prolongation.

Main Results:

  • Consistent demonstration of anti-tumour activity in a small patient percentage.
  • Ongoing modification of dose and schedule for current agents.
  • Development of new agents to enhance therapeutic approaches.

Conclusions:

  • Immunotherapy offers a demonstrated, albeit limited, anti-tumour effect in metastatic renal cell cancer.
  • Further research into novel immune activation technologies is crucial.
  • New agents are being developed to enhance the anti-proliferative and disease-stabilizing effects of immunotherapy.

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...